Hematology TimesInhibitor outperforms rivals in leukemia, lymphomaApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesTeam uses iPSCs to create ‘universal’ CAR T cellsApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsPDPK1 could be novel target in MCLApril 13, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesResearch reveals new subtypes of DLBCLApril 12, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeNew genetic subtypes could facilitate precision medicine in DLBCLApril 11, 2018Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology TimesTazemetostat exhibits antitumor activity in phase 1 trialApril 11, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesCombo improves outcomes in MCLApril 10, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDuvelisib NDA granted priority reviewApril 10, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesProject provides ‘unprecedented understanding’ of cancersApril 6, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesAMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsLenalidomide yields responses in a rare cutaneous lymphomaApril 3, 2018Aggressive LymphomasRare DiseasesLymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
Hematology NewsIbrutinib plus venetoclax is active in mantle cell lymphomaMarch 28, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsVIDEO: How to prepare PTCL patients for transplantMarch 27, 2018T Cell LymphomasAggressive Lymphomas
Hematology TimesICER assesses value of CAR T-cell therapiesMarch 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesHealth Canada approves SC rituximab for CLLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyAggressive Lymphomas
Hematology NewsExperimental voxtalisib shows mixed results in phase 2 studyMarch 22, 2018CLLAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
